CN102552674B - 一种治疗肾病综合征的中药药物 - Google Patents
一种治疗肾病综合征的中药药物 Download PDFInfo
- Publication number
- CN102552674B CN102552674B CN2012100293499A CN201210029349A CN102552674B CN 102552674 B CN102552674 B CN 102552674B CN 2012100293499 A CN2012100293499 A CN 2012100293499A CN 201210029349 A CN201210029349 A CN 201210029349A CN 102552674 B CN102552674 B CN 102552674B
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- chinese medicine
- nephrotic syndrome
- traditional chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000003814 drug Substances 0.000 title claims abstract description 46
- 206010029164 Nephrotic syndrome Diseases 0.000 title claims abstract description 26
- 239000002994 raw material Substances 0.000 claims abstract description 7
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 5
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 5
- 235000008434 ginseng Nutrition 0.000 claims abstract description 5
- 210000000582 semen Anatomy 0.000 claims abstract description 5
- 238000002360 preparation method Methods 0.000 claims description 12
- 241000208340 Araliaceae Species 0.000 claims description 4
- 241000628997 Flos Species 0.000 claims description 4
- 210000003038 endothelium Anatomy 0.000 claims description 4
- 239000010271 massa medicata fermentata Substances 0.000 claims description 4
- 241000605447 Anemarrhena Species 0.000 claims description 3
- 241000545442 Radix Species 0.000 claims description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 11
- 201000010099 disease Diseases 0.000 abstract description 9
- 231100000957 no side effect Toxicity 0.000 abstract description 3
- 230000008901 benefit Effects 0.000 abstract description 2
- 238000004519 manufacturing process Methods 0.000 abstract description 2
- 231100000252 nontoxic Toxicity 0.000 abstract description 2
- 230000003000 nontoxic effect Effects 0.000 abstract description 2
- 241000173529 Aconitum napellus Species 0.000 abstract 1
- 240000004510 Agastache rugosa Species 0.000 abstract 1
- 244000061520 Angelica archangelica Species 0.000 abstract 1
- 241000510667 Conioselinum Species 0.000 abstract 1
- 241000287828 Gallus gallus Species 0.000 abstract 1
- 235000001287 Guettarda speciosa Nutrition 0.000 abstract 1
- 244000241838 Lycium barbarum Species 0.000 abstract 1
- 235000015459 Lycium barbarum Nutrition 0.000 abstract 1
- 235000015468 Lycium chinense Nutrition 0.000 abstract 1
- 229930195210 Ophiopogon Natural products 0.000 abstract 1
- 244000248557 Ophiopogon japonicus Species 0.000 abstract 1
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 244000299790 Rheum rhabarbarum Species 0.000 abstract 1
- 235000009411 Rheum rhabarbarum Nutrition 0.000 abstract 1
- 229940023019 aconite Drugs 0.000 abstract 1
- 235000013330 chicken meat Nutrition 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 26
- 210000003734 kidney Anatomy 0.000 description 16
- 206010030113 Oedema Diseases 0.000 description 15
- 102000004169 proteins and genes Human genes 0.000 description 12
- 108090000623 proteins and genes Proteins 0.000 description 12
- 210000000952 spleen Anatomy 0.000 description 11
- 210000002700 urine Anatomy 0.000 description 11
- 229940079593 drug Drugs 0.000 description 10
- 230000000694 effects Effects 0.000 description 9
- 239000000203 mixture Substances 0.000 description 8
- 238000001914 filtration Methods 0.000 description 7
- 230000006870 function Effects 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 6
- 239000008280 blood Substances 0.000 description 6
- 239000000706 filtrate Substances 0.000 description 6
- 208000034767 Hypoproteinaemia Diseases 0.000 description 5
- 201000001474 proteinuria Diseases 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- 238000001816 cooling Methods 0.000 description 4
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 208000022461 Glomerular disease Diseases 0.000 description 3
- 108060003951 Immunoglobulin Proteins 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 201000005577 familial hyperlipidemia Diseases 0.000 description 3
- 102000018358 immunoglobulin Human genes 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 208000011580 syndromic disease Diseases 0.000 description 3
- 238000002562 urinalysis Methods 0.000 description 3
- 230000002485 urinary effect Effects 0.000 description 3
- 102000004506 Blood Proteins Human genes 0.000 description 2
- 108010017384 Blood Proteins Proteins 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- 230000001174 ascending effect Effects 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 229940109239 creatinine Drugs 0.000 description 2
- 229940127089 cytotoxic agent Drugs 0.000 description 2
- 239000002254 cytotoxic agent Substances 0.000 description 2
- 239000002934 diuretic Substances 0.000 description 2
- 230000001882 diuretic effect Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 231100000852 glomerular disease Toxicity 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 229960003444 immunosuppressant agent Drugs 0.000 description 2
- 230000001861 immunosuppressant effect Effects 0.000 description 2
- 239000003018 immunosuppressive agent Substances 0.000 description 2
- 208000017169 kidney disease Diseases 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 210000003141 lower extremity Anatomy 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 230000008506 pathogenesis Effects 0.000 description 2
- 239000008194 pharmaceutical composition Substances 0.000 description 2
- 210000002381 plasma Anatomy 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 229960004618 prednisone Drugs 0.000 description 2
- XOFYZVNMUHMLCC-ZPOLXVRWSA-N prednisone Chemical compound O=C1C=C[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 XOFYZVNMUHMLCC-ZPOLXVRWSA-N 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000032258 transport Effects 0.000 description 2
- 239000011800 void material Substances 0.000 description 2
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 206010001580 Albuminuria Diseases 0.000 description 1
- 241001116389 Aloe Species 0.000 description 1
- 241000218236 Cannabis Species 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 206010011655 Cushingoid Diseases 0.000 description 1
- CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 description 1
- 102000003951 Erythropoietin Human genes 0.000 description 1
- 108090000394 Erythropoietin Proteins 0.000 description 1
- 206010018092 Generalised oedema Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 208000028782 Hereditary disease Diseases 0.000 description 1
- 239000009636 Huang Qi Substances 0.000 description 1
- 208000003623 Hypoalbuminemia Diseases 0.000 description 1
- 208000026350 Inborn Genetic disease Diseases 0.000 description 1
- 206010061245 Internal injury Diseases 0.000 description 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 1
- 208000024556 Mendelian disease Diseases 0.000 description 1
- 102000007562 Serum Albumin Human genes 0.000 description 1
- 108010071390 Serum Albumin Proteins 0.000 description 1
- 208000032023 Signs and Symptoms Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- PNNCWTXUWKENPE-UHFFFAOYSA-N [N].NC(N)=O Chemical compound [N].NC(N)=O PNNCWTXUWKENPE-UHFFFAOYSA-N 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 235000011399 aloe vera Nutrition 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- GMRQFYUYWCNGIN-NKMMMXOESA-N calcitriol Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@@H](CCCC(C)(C)O)C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C GMRQFYUYWCNGIN-NKMMMXOESA-N 0.000 description 1
- 229960005084 calcitriol Drugs 0.000 description 1
- 235000020964 calcitriol Nutrition 0.000 description 1
- 239000011612 calcitriol Substances 0.000 description 1
- 239000007963 capsule composition Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 239000000571 coke Substances 0.000 description 1
- 230000002016 colloidosmotic effect Effects 0.000 description 1
- 238000002648 combination therapy Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 229960004397 cyclophosphamide Drugs 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 230000007368 endocrine function Effects 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 229940105423 erythropoietin Drugs 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 238000002309 gasification Methods 0.000 description 1
- 210000000585 glomerular basement membrane Anatomy 0.000 description 1
- 230000024924 glomerular filtration Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000009569 green tea Nutrition 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000001794 hormone therapy Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- OXCMYAYHXIHQOA-UHFFFAOYSA-N potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,4-triaza-3-azanidacyclopenta-1,4-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol Chemical compound [K+].CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C2=N[N-]N=N2)C=C1 OXCMYAYHXIHQOA-UHFFFAOYSA-N 0.000 description 1
- 229960005205 prednisolone Drugs 0.000 description 1
- OIGNJSKKLXVSLS-VWUMJDOOSA-N prednisolone Chemical compound O=C1C=C[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 OIGNJSKKLXVSLS-VWUMJDOOSA-N 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 208000017443 reproductive system disease Diseases 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000003625 skull Anatomy 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 238000011285 therapeutic regimen Methods 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 210000005239 tubule Anatomy 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2012100293499A CN102552674B (zh) | 2012-02-10 | 2012-02-10 | 一种治疗肾病综合征的中药药物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2012100293499A CN102552674B (zh) | 2012-02-10 | 2012-02-10 | 一种治疗肾病综合征的中药药物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102552674A CN102552674A (zh) | 2012-07-11 |
CN102552674B true CN102552674B (zh) | 2013-06-05 |
Family
ID=46400128
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2012100293499A Active CN102552674B (zh) | 2012-02-10 | 2012-02-10 | 一种治疗肾病综合征的中药药物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102552674B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104771587A (zh) * | 2015-04-26 | 2015-07-15 | 黄萍 | 一种治疗气阴两虚型肾病综合征的中药组合物 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101502619A (zh) * | 2009-03-27 | 2009-08-12 | 刘云 | 治疗慢性肾功能衰竭的中药 |
-
2012
- 2012-02-10 CN CN2012100293499A patent/CN102552674B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN102552674A (zh) | 2012-07-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101757540A (zh) | 一种治疗肾病综合征的中药组合物及其制备方法 | |
CN102106957A (zh) | 一种治疗高血脂的中药组合物 | |
CN103272194B (zh) | 一种治疗妇科月经不调的药物 | |
CN106362104A (zh) | 一种治疗青春期多囊卵巢综合征的药物组合物 | |
CN104524071A (zh) | 一种治疗原发性肾病的药物组合物及其用途 | |
CN101912597A (zh) | 一种治疗老年性痴呆症的药物及其制备方法 | |
CN103948791A (zh) | 一种降血脂的中药组合物及其制备方法 | |
CN101912596B (zh) | 一种治疗过敏性鼻炎的药物及其制备方法 | |
CN103520665A (zh) | 一种孕妇妊娠初期安胎的中药及其制备方法 | |
CN103638135B (zh) | 清浊益肾胶囊 | |
CN102552674B (zh) | 一种治疗肾病综合征的中药药物 | |
CN103263650B (zh) | 一种调理女性月经的中药 | |
CN104644967A (zh) | 一种治疗i型糖尿病的药物组合物及其应用 | |
CN102125671B (zh) | 一种治疗肾虚阴冷所致妇科疾病的中药组合物及制备方法 | |
CN104436121B (zh) | 一种治疗月经不调、小腹胀满、久不受孕的药物 | |
CN103041233A (zh) | 一种治疗小儿腹泻的药物组合物及其制备方法 | |
CN104888124A (zh) | 盐酸米安色林的合成工艺及其检测方法 | |
CN105362682A (zh) | 一种治疗月经过少的外用药物 | |
CN104383349A (zh) | 一种用于膀胱癌术后恢复的药物及其制备方法 | |
CN109876127A (zh) | 一种养血当归胶囊及其制备方法 | |
CN102357218B (zh) | 一种治疗月经不调的中药组合物 | |
CN103301374B (zh) | 一种治疗产后非特异性阴道炎的药物组合物 | |
CN108310207B (zh) | 一种治疗心力衰竭的药物组合物及其制备方法 | |
CN102357179B (zh) | 治疗抗精子抗体致不孕症或习惯性流产的药物及制备方法 | |
CN106266909A (zh) | 利用生物提取物治疗心脑血管病的含片及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: JIANGSU HUAXINYUAN PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: LI LI Effective date: 20141231 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 276002 LINYI, SHANDONG PROVINCE TO: 226500 NANTONG, JIANGSU PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20141231 Address after: 226500 Jiangsu city of Rugao Province Town North Street Flower Market Road No. 20 Patentee after: Jiangsu Xinyuan Pharmaceutical Co., Ltd. Address before: 276002 Department of nephropathy, Linyi Hospital of traditional Chinese medicine, Jiefang Road 211, Linyi, Shandong Patentee before: Li Li |